TY - JOUR
T1 - Viral PCR positivity in stool before allogeneic hematopoietic cell transplantation is strongly associated with acute intestinal graft-versus-host disease
AU - van Montfrans, Joris
AU - Schulz, Laura
AU - Versluys, Birgitta
AU - de Wildt, Arianne
AU - Wolfs, Tom
AU - Bierings, Marc
AU - Gerhardt, Corinne
AU - Lindemans, Caroline
AU - Wensing, Anne
AU - Boelens, Jaap Jan
N1 - Publisher Copyright:
© 2015 American Society for Blood and Marrow Transplantation.
PY - 2015/4/1
Y1 - 2015/4/1
N2 - Acute graft-versus-host disease (aGVHD) can be triggered by inflammatory conditions, including infections and mucositis. We investigated the association between PCR positivity for gastrointestinal (GI) viruses in stool before hematopoietic cell transplantation (HCT) and intestinal aGVHD using Cox proportional hazard models. We included 48 consecutive HCT patients (28 with malignancies and 20 with nonmalignancies) without GI symptoms before HCT. Fifteen patients were GI virus positive: 9 adenovirus, 3 norovirus, 2 parechovirus, and 1 astrovirus. Overall survival was 58%±8%. The cumulative incidence of aGVHD grade 2 to 4 was 43%±8% (n=18) after a median of 47days (range, 14 to 140). In univariate analysis, GI virus PCR positivity was the only predictor for aGVHD (P=008): within the group of GI virus PCR-positive patients, the cumulative incidence of aGVHD 2 to 4 was 70%±12% versus 29±8% in the PCR-negative group (P=004). In conclusion, GI virus PCR positivity before HCT predicted development of intestinal aGVHD. These results may ultimately affect monitoring, aGVHD prophylaxis, and treatment, as well as rescheduling of elective HCTs.
AB - Acute graft-versus-host disease (aGVHD) can be triggered by inflammatory conditions, including infections and mucositis. We investigated the association between PCR positivity for gastrointestinal (GI) viruses in stool before hematopoietic cell transplantation (HCT) and intestinal aGVHD using Cox proportional hazard models. We included 48 consecutive HCT patients (28 with malignancies and 20 with nonmalignancies) without GI symptoms before HCT. Fifteen patients were GI virus positive: 9 adenovirus, 3 norovirus, 2 parechovirus, and 1 astrovirus. Overall survival was 58%±8%. The cumulative incidence of aGVHD grade 2 to 4 was 43%±8% (n=18) after a median of 47days (range, 14 to 140). In univariate analysis, GI virus PCR positivity was the only predictor for aGVHD (P=008): within the group of GI virus PCR-positive patients, the cumulative incidence of aGVHD 2 to 4 was 70%±12% versus 29±8% in the PCR-negative group (P=004). In conclusion, GI virus PCR positivity before HCT predicted development of intestinal aGVHD. These results may ultimately affect monitoring, aGVHD prophylaxis, and treatment, as well as rescheduling of elective HCTs.
KW - Graft-versus-host disease (GVHD)
KW - Hematopoietic cell transplantation (HCT)
KW - Outcome
KW - Virus
UR - http://www.scopus.com/inward/record.url?scp=84924254505&partnerID=8YFLogxK
U2 - 10.1016/j.bbmt.2015.01.009
DO - 10.1016/j.bbmt.2015.01.009
M3 - Article
C2 - 25598276
AN - SCOPUS:84924254505
SN - 1083-8791
VL - 21
SP - 772
EP - 774
JO - Biology of Blood and Marrow Transplantation
JF - Biology of Blood and Marrow Transplantation
IS - 4
ER -